ATE431415T1 - Hiv impfstoff - Google Patents

Hiv impfstoff

Info

Publication number: ATE431415T1
Authority: AT; Austria
Prior art keywords: hiv vaccine; vaccine; hiv
Prior art date: 1998-08-12

Application number

AT99938094T

Other languages

English (en)

Inventor

Chil-Yong Kang

Yan Li

Original Assignee

Univ Western Ontario

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-12

Filing date

1999-08-12

Publication date

2009-05-15

1999-08-12 Application filed by Univ Western Ontario filed Critical Univ Western Ontario

2009-05-15 Application granted granted Critical

2009-05-15 Publication of ATE431415T1 publication Critical patent/ATE431415T1/de

Links

229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16061—Methods of inactivation or attenuation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Microbiology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

AT99938094T 1998-08-12 1999-08-12 Hiv impfstoff ATE431415T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9623598P	1998-08-12	1998-08-12
PCT/CA1999/000746 WO2000009703A1 (en)	1998-08-12	1999-08-12	Hiv vaccine

Publications (1)

Publication Number	Publication Date
ATE431415T1 true ATE431415T1 (de)	2009-05-15

Family

ID=22256483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99938094T ATE431415T1 (de)	1998-08-12	1999-08-12	Hiv impfstoff

Country Status (14)

Country	Link
EP (1)	EP1105498B1 (de)
KR (1)	KR100689249B1 (de)
CN (1)	CN1206355C (de)
AP (1)	AP1561A (de)
AT (1)	ATE431415T1 (de)
AU (1)	AU5274099A (de)
CA (1)	CA2339850C (de)
DE (1)	DE69940886D1 (de)
DK (1)	DK1105498T3 (de)
ES (1)	ES2327300T3 (de)
OA (1)	OA11598A (de)
PT (1)	PT1105498E (de)
WO (1)	WO2000009703A1 (de)
ZA (1)	ZA200100941B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7608273B2 (en) *	1998-08-12	2009-10-27	University Of Western Ontario	Recombinant lentivirus encoding modified GP 120 signal sequences
WO2005012535A2 (en) *	2003-08-01	2005-02-10	Phytovation B.V.	Method for producing life attenuated viruses and use of viral particles thus produced.
CN111701016A (zh) *	2020-06-28	2020-09-25	张全志	逆转录病毒原病毒序列在逆转录病毒疫苗设计中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994017825A1 (en) *	1993-02-05	1994-08-18	The Regents Of The University Of California	Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use

1999
- 1999-08-12 WO PCT/CA1999/000746 patent/WO2000009703A1/en not_active Ceased
- 1999-08-12 AU AU52740/99A patent/AU5274099A/en not_active Abandoned
- 1999-08-12 DE DE69940886T patent/DE69940886D1/de not_active Expired - Lifetime
- 1999-08-12 CA CA2339850A patent/CA2339850C/en not_active Expired - Lifetime
- 1999-08-12 CN CNB998108529A patent/CN1206355C/zh not_active Expired - Lifetime
- 1999-08-12 ES ES99938094T patent/ES2327300T3/es not_active Expired - Lifetime
- 1999-08-12 PT PT99938094T patent/PT1105498E/pt unknown
- 1999-08-12 DK DK99938094T patent/DK1105498T3/da active
- 1999-08-12 EP EP99938094A patent/EP1105498B1/de not_active Expired - Lifetime
- 1999-08-12 AP APAP/P/2001/002076A patent/AP1561A/en active
- 1999-08-12 KR KR1020017001836A patent/KR100689249B1/ko not_active Expired - Fee Related
- 1999-08-12 AT AT99938094T patent/ATE431415T1/de active
- 1999-08-12 OA OA1200100041A patent/OA11598A/en unknown
2001
- 2001-02-02 ZA ZA200100941A patent/ZA200100941B/en unknown

Also Published As

Publication number	Publication date
CN1206355C (zh)	2005-06-15
EP1105498A1 (de)	2001-06-13
KR100689249B1 (ko)	2007-03-08
KR20010072436A (ko)	2001-07-31
PT1105498E (pt)	2009-08-13
OA11598A (en)	2004-07-30
ZA200100941B (en)	2002-02-04
AU5274099A (en)	2000-03-06
ES2327300T3 (es)	2009-10-27
CA2339850C (en)	2011-10-04
AP2001002076A0 (en)	2001-03-31
DK1105498T3 (da)	2009-08-31
CA2339850A1 (en)	2000-02-24
AP1561A (en)	2006-02-01
EP1105498B1 (de)	2009-05-13
WO2000009703A1 (en)	2000-02-24
CN1318104A (zh)	2001-10-17
DE69940886D1 (en)	2009-06-25

Legal Events

Date

Code

Title

Description

2010-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1105498

Country of ref document: EP

Publication	Publication Date	Title
NO20003302L (no)	2000-08-18	Vaksine
NO20014323D0 (no)	2001-09-05	Vaksine
NO20006191D0 (no)	2000-12-06	Vaksine
ATE197406T1 (de)	2000-11-11	Influenza vaccine
NO20004758D0 (no)	2000-09-22	Vaksinesammensetning
NO20031483L (no)	2003-05-28	Vaksine
NO2010019I2 (no)	2012-08-27	6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin
DE60045324D1 (de)	2011-01-13	Impfstoffzusammensetzung
IS6040A (is)	2001-08-07	Valdekoxib efnablöndur
NO20024172L (no)	2002-11-01	Vaksine
DE60002650D1 (de)	2003-06-18	Öladjuvierter Impfstoff
NO20020763L (no)	2002-04-16	Vaksine
EE200200150A (et)	2003-04-15	Preparaat
GB9826069D0 (en)	1999-01-20	HIV vaccine
NO20005599D0 (no)	2000-11-06	Vaksine
DK1105498T3 (da)	2009-08-31	HIV vaccine
EP1157700A4 (de)	2003-06-18	Anti-hiv substanz
ITMI981384A0 (it)	1998-06-17	Vaccino per hiv
DE50009295D1 (de)	2005-02-24	Vernetzerfreie zubereitungen
ITMI992410A0 (it)	1999-11-18	Vaccino per hiv
NO20002213D0 (no)	2000-04-28	Babesia vaksine
FIU990234U0 (fi)	1999-05-21	Vuoka
NO20021936D0 (no)	2002-04-24	Diaryl-enyner